Family: commelinaceae
Other known names: Rolla Rao et
Thai names: bakging, ya pakking
Botanical description:
This low growing stem less plant only grows in tropical South East Asia. It has two 10 to 15 cm opposing shiny dark green succulent leaves. The plant thrives in the shade on rich moist soil. The plant reproduces by sending out shoots. It grows in the jungles of Thailand where it is plentiful and can be harvested without endangering the species.
Uses in Ethnic Medicine:
Murdannia loriformis has been known in Thailand for a very long time and is used here for chronic bronchitis and disorders which present symptoms of mutagenic diseases (cancer). Although folk medicine is unable to diagnose the many forms of cancer, this herb is used symptomatically with enormous success.
Traditional Thai Prescriptions:
Fresh Murdannia leaves are steeped in vinegar or saltwater (2 tea spoons) for 20 minutes and then filtered with 2 tablespoons of water through a sieve. The extract is taken twice daily: before the first meal of the day and before sleeping. Murdannia leaves can also be pressed and the extracted juice mixed with fruit juice for better taste. It can also be dried and take three times daily in capsule form, or taken together with honey.
Note: The use of Murdannia requires the expert advice of a therapist to establish the correct dose and to accompany the patient throughout the period of treatment.
Ingredients (leaves):
Rf value 0,23. The majority of the ingredients and active products of Murdannia are similar to those of cannabis india, and they are concentrated in the tips of the leaves which are to be preferred.
Toxicity tests:
No cytotoxic effects on the blood monocular cells were found. An increase in the proliferation of lymphocytes was recorded. It was observed that the change in the CD molecules (CD 3,4, CD 3,8) on the surface of the increased (during an incubation of 3 days) lymphocytes CD3,4 and CD 3,6 were normalized after a further incubation of 7 days.
Pharmacognostic action and trials:
In the author’s research team at the University of Khon Kaen led by Professor Chayan, Murdannia is the subject of a specially intensive research in this faculty in close co-operation with all the other faculties of medicine in this country in spite of the fact that the ‘chemotherapy lobby’ has already gained ground in Thailand, where nevertheless, chemotherapy is more precisely applied than in the West and not as a matter of course in every case. A Thai book by the author’s colleagues (Supaporn Pitiporn, Soodjai Bromkerd) in this research team reports the use of Murdannia in cancer treatment for over 25 years. There have even been reports of cures that have successfully been carried out exclusively with Murdannia. It therefore seems obvious that Murdannia loriformis is an important piece of the complex pattern of cures and therapies for cancer10 and to summarize, it can be concluded that Murdannia is a perfectly suitable adjuvant for radiation and chemotherapy.
The use of Murdannia requires the expert advice of a therapist to establish the correct dose and to accompany the patient throughout the period of treatment.
Taking into account the fact that every doctor who treats tumours is faced with the dilemma of using substances on the one hand which arrest the growth cytotoxically of the tumour cells, which is also immune suppressive, or on the other hand using products, which in view of the essential requirement to stimulate the immune system in cases of life threatening disease, to put the patient in a position where he can overcome the disease through self therapy.
In a study conducted by the University Of Chiang Mai Thailand, it was ascertained that Murdannia loriformis has many antimutagenic effects. It is therefore suitable for curing chronic bronchitis (used together with other antibiotics to combat strains which have become resistant. From this it was further determined that Murdannia stops the growth of tumour cells in the intestine and probably also kills them. It was also proved that Murdannia significantly suppresses the formation of ACF and at the start of the treatment the carcinogens of the colon are suppressed by 56%. Interestingly it was also proved in a long-term treatment with Murdannia that the development of larger AFC (with four or more crypts per foci) was reduced by 27%. Those who were treated with long-term therapy could be considered as cured. The test subjects manifested an after 30 days a significant induced APD, glutathione S transverase and UDP-GT action. It would therefore appear that these detoxicating effects make Murdannia a product that can respond to both demands of cancer therapy mentioned at the beginning. The selective changing of enzymes in the cenobitic metabolism system is also regarded as a possible effect of the mechanism of chemical protection of Murdannia. The extremely mild antioxidant effect had therefore no influence on the undesired effects of tumour therapy.
Murdannia is an immune moderator and induces DT-diaphorase enzymes which play an important role in detoxification. It also protects from aflatoxin B1. Furthermore it reduces the cytomegali titer in children and adults. Whether it attacks the virus cytomegalia infantum or the herpes-similar cytomegalic inclusion disease, and is indeed effective against them both, is not yet fully explained, but treatment with Murdannia of hepato-splenomegalie - with or without icterus (jaundice) – was successful. It is the statistics, prognoses and survival chances which were previously mentioned in earlier chapters which can impair the treatment of these diseases. One fact remains to be repeated, and that is that Thai traditional herbs also have an effect on the mind, and this is especially applicable to Murdannia. In bioresonance trials, Murdannia had extremely good test results, that is. In cancer patients certain areas of the brain are also concerned with the disorder, and many reports will confirm that Murdannia here too, has an effect.
During the first seven days of treatment with Murdannia, patients often complain of unpleasant sensations of slight nausea and general discomfort. After a further seven days patients do show clear signs of improvement of the original symptoms and after a period of about two months bloods tests will show much improved results and the tumours will have reduced.
INDICATIONS: all above mentioned diseases Benign and maligned tumor, as adjuvant with chemo-therapy. Chronic bronchitis
DOSAGE: as directed by a physician
Minimum dosage 3 capsules a day to 400 mg each |
